Can-Fite completes direct public offering

Can-Fite BioPharma Ltd. (Tel Aviv:CFBI; NYSE-M:CANF), Petah Tikva, Israel Business: Cancer, Infectious, Autoimmune Date completed: 2015-10-13 Type: Direct public offering Raised: $4.8 million Shares: ...